BIOCYTOGEN PHARMACEUTICALS (BEIJING revenue for the last year amounted to 788.70 M HKD, the most of which — 301.45 M HKD — came from its highest performing source at the moment, Animal Models Selling, the year earlier bringing 196.91 M HKD. The greatest contribution to the revenue figure was made by China — last year it brought BIOCYTOGEN PHARMACEUTICALS (BEIJING 341.01 M HKD, and the year before that — 334.60 M HKD.